Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Cor's Bob Messerschmidt to Teach Precision Health and Crowdfunding Masterclass at Stanford Medicine X

Posted on: 15 Sep 16

PR Newswire

SAN FRANCISCO, Sept. 15, 2016

SAN FRANCISCO, Sept. 15, 2016 /PRNewswire/ -- Bob Messerschmidt, CEO and founder of Cor, is among a select group of innovators scheduled to teach at this year's Stanford Medicine X on Sunday, September 18. Messerschmidt's masterclass titled, "The Transformation of Precision Health in the Home, and Crowdfunding," will explore the future of health as it relates to customization and personalization, and advancements made in managing personal health.

Messerschmidt's 90-minute course will cover the profound changes transpiring in the medical industry, specifically focusing on the shift from healthcare to health--a recent phenomenon in the health industry that stems from the idea of moving from a disease centered model to a patient centered model of care. Attendees will be encouraged to think critically about the state of the industry, while understanding how precision medicine relates to customized healthcare and personal medicine.

To further supplement the course, Messerschmidt will share his personal experience developing his latest advancement, Cor, and discuss how crowdfunding is playing a vital role in the support and development of wellness innovations. Cor delivers personalized health insights from a single drop of blood, and officially launched on Indiegogo, raising more than 231 percent of the company's initial goal.

"It's quite an honor to be invited back for a second time at Stanford Medicine X," said Bob Messerschmidt. "Stanford is the leading research institution in the world and the Medicine X program is truly reflective of that. I'm looking forward to joining other educators and bringing engaging, valuable content to the bright minds who will one day innovate and continue our charge for better health and healthcare for all."

Cor is on a bold mission to bring at-home health monitoring to the next level by delivering personalized insights all from a single microdrop of blood. The company is developing a patented state of the art spectroscopic technology to report overall trends and offer lifestyle recommendations based on indicators such as cholesterol, fasting blood glucose, inflammation and triglycerides.

Since 2001, Stanford Medicine X has been a catalyst for new ideas about the future of medicine and healthcare. This conference will explore how emerging technologies advance the practice of medicine, improve health and empower patients to be active participants of their own wellbeing. For the past six years, attendees have been invited to learn from the top visionaries disrupting healthcare, learning new ways to progress the medicine of tomorrow.

In addition to Messerschmidt's masterclass, over 160 innovators and researchers will attend the conference to present high-quality breakout sessions. Sessions range from five-minute presentations to interactive 90-minute workshops falling under the following tracks: business, design, ePatient, implementation and research.

To learn more about Bob Messerschmidt and Cor, please visit: You can register to attend Stanford Medicine X by visiting:

About Cor
Cor is a powerful general wellness product that delivers personalized health insights from a single drop of blood. The Cor Reader uses patented vibrational spectroscopic technology to analyze a surface-level blood sample and report overall trends. The Cor App then delivers key insights and lifestyle improvement recommendations related to indicators such as cholesterol, fasting blood glucose, inflammation and triglycerides. Cor was founded in 2014 by Bob Messerschmidt and is backed by world-class medical advisors from Stanford, UCSF and Duke University. To learn more, visit


To view the original version on PR Newswire, visit:


PR Newswire

Last updated on: 15/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.